British Sarcoma Group

Executive Office 35 Sandford Avenue Church Stretton Shropshire SY6 6BH Telephone 01694 722123

Trial Name	PICASSO III
Description	A study to evaluate the clinical benefit of palifosfamide tris administered with doxorubicin in combination, compared with single-agent doxorubicin for patients with unresectable or metastatic soft-tissue sarcoma
Reference	NCRN 193 ISCRTN 63733470 Sponsor: Ziopharm
Status / Sites	Open London (Royal Marsden), Manchester
UK Chief Investigator Contact	Prof Ian Judson, London

You are viewing the text version of this site.

To view the full version please install the Adobe Flash Player and ensure your web browser has JavaScript enabled.

Need help? check the requirements page.